APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-herpesvirus Agent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-herpesvirus Agent Market Analysis and Forecast 2026-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchAnti-herpesvirus Agent Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-herpesvirus Agent Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Anti-herpesvirus Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-herpesvirus Agent Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-herpesvirus Agent Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Anti-herpesvirus Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Anti-herpesvirus Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-herpesvirus Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-herpesvirus Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-herpesvirus Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Anti-herpesvirus Agent include Maruho Co., Ltd., Asahi Kasei Corporation and AiCuris, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Anti-herpesvirus Agent, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-herpesvirus Agent, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-herpesvirus Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-herpesvirus Agent revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-herpesvirus Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anti-herpesvirus Agent revenue, projected growth trends, production technology, application and end-user industry.

Anti-herpesvirus Agent Segment by Company

Maruho Co., Ltd.

Asahi Kasei Corporation

AiCuris

Anti-herpesvirus Agent Segment by Type

Amenamevir

Famciclovir

Anti-herpesvirus Agent Segment by Application

Medical Field

Other

Anti-herpesvirus Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-herpesvirus Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-herpesvirus Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-herpesvirus Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Anti-herpesvirus Agent in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Anti-herpesvirus Agent company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-herpesvirus Agent revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-herpesvirus Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Amenamevir Major Player Table 3. Famciclovir Major Player Table 4. Global Anti-herpesvirus Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Field Major Player Table 6. Other Major Player Table 7. Anti-herpesvirus Agent Industry Trends Table 8. Anti-herpesvirus Agent Industry Drivers Table 9. Anti-herpesvirus Agent Industry Opportunities and Challenges Table 10. Anti-herpesvirus Agent Industry Restraints Table 11. Global Anti-herpesvirus Agent Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Anti-herpesvirus Agent Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Anti-herpesvirus Agent Market Share by Region (2021-2026) Table 14. Global Anti-herpesvirus Agent Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Anti-herpesvirus Agent Market Share by Region (2027-2032) Table 16. Global Anti-herpesvirus Agent Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Anti-herpesvirus Agent Revenue Market Share by Players (2021-2026) Table 18. Global Anti-herpesvirus Agent Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Anti-herpesvirus Agent Key Players Headquarters & Area Served Table 20. Global Anti-herpesvirus Agent Players, Product Type & Application Table 21. Global Anti-herpesvirus Agent Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Anti-herpesvirus Agent by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Anti-herpesvirus Agent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Anti-herpesvirus Agent Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Anti-herpesvirus Agent Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Anti-herpesvirus Agent Revenue Market Share by Type (2021-2026) Table 28. Global Anti-herpesvirus Agent Revenue Market Share by Type (2027-2032) Table 29. Global Anti-herpesvirus Agent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Anti-herpesvirus Agent Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Anti-herpesvirus Agent Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Anti-herpesvirus Agent Revenue Market Share by Application (2021-2026) Table 33. Global Anti-herpesvirus Agent Revenue Market Share by Application (2027-2032) Table 34. Maruho Co., Ltd. Company Information Table 35. Maruho Co., Ltd. Business Overview Table 36. Maruho Co., Ltd. Anti-herpesvirus Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Maruho Co., Ltd. Anti-herpesvirus Agent Product Portfolio Table 38. Maruho Co., Ltd. Recent Development Table 39. Asahi Kasei Corporation Company Information Table 40. Asahi Kasei Corporation Business Overview Table 41. Asahi Kasei Corporation Anti-herpesvirus Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Asahi Kasei Corporation Anti-herpesvirus Agent Product Portfolio Table 43. Asahi Kasei Corporation Recent Development Table 44. AiCuris Company Information Table 45. AiCuris Business Overview Table 46. AiCuris Anti-herpesvirus Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. AiCuris Anti-herpesvirus Agent Product Portfolio Table 48. AiCuris Recent Development Table 49. North America Anti-herpesvirus Agent Revenue by Type (2021-2026) & (US$ Million) Table 50. North America Anti-herpesvirus Agent Revenue by Type (2027-2032) & (US$ Million) Table 51. North America Anti-herpesvirus Agent Revenue by Application (2021-2026) & (US$ Million) Table 52. North America Anti-herpesvirus Agent Revenue by Application (2027-2032) & (US$ Million) Table 53. North America Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America Anti-herpesvirus Agent Revenue by Country (2021-2026) & (US$ Million) Table 55. North America Anti-herpesvirus Agent Revenue by Country (US$ Million) & (2027-2032) Table 56. Europe Anti-herpesvirus Agent Revenue by Type (2021-2026) & (US$ Million) Table 57. Europe Anti-herpesvirus Agent Revenue by Type (2027-2032) & (US$ Million) Table 58. Europe Anti-herpesvirus Agent Revenue by Application (2021-2026) & (US$ Million) Table 59. Europe Anti-herpesvirus Agent Revenue by Application (2027-2032) & (US$ Million) Table 60. Europe Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe Anti-herpesvirus Agent Revenue by Country (2021-2026) & (US$ Million) Table 62. Europe Anti-herpesvirus Agent Revenue by Country (US$ Million) & (2027-2032) Table 63. China Anti-herpesvirus Agent Revenue by Type (2021-2026) & (US$ Million) Table 64. China Anti-herpesvirus Agent Revenue by Type (2027-2032) & (US$ Million) Table 65. China Anti-herpesvirus Agent Revenue by Application (2021-2026) & (US$ Million) Table 66. China Anti-herpesvirus Agent Revenue by Application (2027-2032) & (US$ Million) Table 67. Asia Anti-herpesvirus Agent Revenue by Type (2021-2026) & (US$ Million) Table 68. Asia Anti-herpesvirus Agent Revenue by Type (2027-2032) & (US$ Million) Table 69. Asia Anti-herpesvirus Agent Revenue by Application (2021-2026) & (US$ Million) Table 70. Asia Anti-herpesvirus Agent Revenue by Application (2027-2032) & (US$ Million) Table 71. Asia Anti-herpesvirus Agent Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia Anti-herpesvirus Agent Revenue by Region (US$ Million) & (2021-2026) Table 73. Asia Anti-herpesvirus Agent Revenue by Region (US$ Million) & (2027-2032) Table 74. SAMEA Anti-herpesvirus Agent Revenue by Type (2021-2026) & (US$ Million) Table 75. SAMEA Anti-herpesvirus Agent Revenue by Type (2027-2032) & (US$ Million) Table 76. SAMEA Anti-herpesvirus Agent Revenue by Application (2021-2026) & (US$ Million) Table 77. SAMEA Anti-herpesvirus Agent Revenue by Application (2027-2032) & (US$ Million) Table 78. SAMEA Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. SAMEA Anti-herpesvirus Agent Revenue by Country (2021-2026) & (US$ Million) Table 80. SAMEA Anti-herpesvirus Agent Revenue by Country (US$ Million) & (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Anti-herpesvirus Agent Image Figure 2. Global Anti-herpesvirus Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-herpesvirus Agent Market Size Share 2021 VS 2025 VS 2032 Figure 4. Amenamevir Image Figure 5. Famciclovir Image Figure 6. Global Anti-herpesvirus Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Anti-herpesvirus Agent Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Field Image Figure 9. Other Image Figure 10. Global Anti-herpesvirus Agent Market Size (US$ Million) & (2021-2032) Figure 11. Global Anti-herpesvirus Agent Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Anti-herpesvirus Agent Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Anti-herpesvirus Agent Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Anti-herpesvirus Agent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anti-herpesvirus Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-herpesvirus Agent Revenue Market Share by Type (2021-2032) Figure 18. Global Anti-herpesvirus Agent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Anti-herpesvirus Agent Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Anti-herpesvirus Agent Revenue Market Share by Application (2021-2032) Figure 21. North America Anti-herpesvirus Agent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Anti-herpesvirus Agent Revenue Share by Type (2021-2032) Figure 23. North America Anti-herpesvirus Agent Revenue Share by Application (2021-2032) Figure 24. North America Anti-herpesvirus Agent Revenue Share by Country (2021-2032) Figure 25. United States Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Anti-herpesvirus Agent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Anti-herpesvirus Agent Revenue Share by Type (2021-2032) Figure 30. Europe Anti-herpesvirus Agent Revenue Share by Application (2021-2032) Figure 31. Europe Anti-herpesvirus Agent Revenue Share by Country (2021-2032) Figure 32. Germany Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Anti-herpesvirus Agent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Anti-herpesvirus Agent Revenue Share by Type (2021-2032) Figure 42. China Anti-herpesvirus Agent Revenue Share by Application (2021-2032) Figure 43. Asia Anti-herpesvirus Agent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Anti-herpesvirus Agent Revenue Share by Type (2021-2032) Figure 45. Asia Anti-herpesvirus Agent Revenue Share by Application (2021-2032) Figure 46. Asia Anti-herpesvirus Agent Revenue Share by Region (2021-2032) Figure 47. Japan Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Anti-herpesvirus Agent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Anti-herpesvirus Agent Revenue Share by Type (2021-2032) Figure 55. SAMEA Anti-herpesvirus Agent Revenue Share by Application (2021-2032) Figure 56. SAMEA Anti-herpesvirus Agent Revenue Share by Country (2021-2032) Figure 57. Brazil Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Anti-herpesvirus Agent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Amenamevir
  • Famciclovir
Applications
  • Medical Field
  • Other
Companies covered
  • Maruho Co., Ltd.
  • Asahi Kasei Corporation
  • AiCuris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-herpesvirus Agent Market by Type
  3. 1.2.1 Global Anti-herpesvirus Agent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Amenamevir
  5. 1.2.3 Famciclovir
  6. 1.3 Anti-herpesvirus Agent Market by Application
  7. 1.3.1 Global Anti-herpesvirus Agent Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Field
  9. 1.3.3 Other
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Anti-herpesvirus Agent Market Dynamics
  1. 2.1 Anti-herpesvirus Agent Industry Trends
  2. 2.2 Anti-herpesvirus Agent Industry Drivers
  3. 2.3 Anti-herpesvirus Agent Industry Opportunities and Challenges
  4. 2.4 Anti-herpesvirus Agent Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Anti-herpesvirus Agent Market Perspective (2021-2032)
  2. 3.2 Global Anti-herpesvirus Agent Growth Trends by Region
  3. 3.2.1 Global Anti-herpesvirus Agent Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-herpesvirus Agent Market Size by Region (2021-2026)
  5. 3.2.3 Global Anti-herpesvirus Agent Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Anti-herpesvirus Agent Revenue by Players
  2. 4.1.1 Global Anti-herpesvirus Agent Revenue by Players (2021-2026)
  3. 4.1.2 Global Anti-herpesvirus Agent Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Anti-herpesvirus Agent Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-herpesvirus Agent Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Anti-herpesvirus Agent Key Players Headquarters & Area Served
  7. 4.4 Global Anti-herpesvirus Agent Players, Product Type & Application
  8. 4.5 Global Anti-herpesvirus Agent Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Anti-herpesvirus Agent Market CR5 and HHI
  11. 4.6.3 2025 Anti-herpesvirus Agent Tier 1, Tier 2, and Tier 3
5 Anti-herpesvirus Agent Market Size by Type
  1. 5.1 Global Anti-herpesvirus Agent Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-herpesvirus Agent Revenue by Type (2021-2032)
  3. 5.3 Global Anti-herpesvirus Agent Revenue Market Share by Type (2021-2032)
6 Anti-herpesvirus Agent Market Size by Application
  1. 6.1 Global Anti-herpesvirus Agent Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Anti-herpesvirus Agent Revenue by Application (2021-2032)
  3. 6.3 Global Anti-herpesvirus Agent Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Maruho Co., Ltd.
  2. 7.1.1 Maruho Co., Ltd. Company Information
  3. 7.1.2 Maruho Co., Ltd. Business Overview
  4. 7.1.3 Maruho Co., Ltd. Anti-herpesvirus Agent Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Maruho Co., Ltd. Anti-herpesvirus Agent Product Portfolio
  6. 7.1.5 Maruho Co., Ltd. Recent Developments
  7. 7.2 Asahi Kasei Corporation
  8. 7.2.1 Asahi Kasei Corporation Company Information
  9. 7.2.2 Asahi Kasei Corporation Business Overview
  10. 7.2.3 Asahi Kasei Corporation Anti-herpesvirus Agent Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Asahi Kasei Corporation Anti-herpesvirus Agent Product Portfolio
  12. 7.2.5 Asahi Kasei Corporation Recent Developments
  13. 7.3 AiCuris
  14. 7.3.1 AiCuris Company Information
  15. 7.3.2 AiCuris Business Overview
  16. 7.3.3 AiCuris Anti-herpesvirus Agent Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AiCuris Anti-herpesvirus Agent Product Portfolio
  18. 7.3.5 AiCuris Recent Developments
8 North America
  1. 8.1 North America Anti-herpesvirus Agent Revenue (2021-2032)
  2. 8.2 North America Anti-herpesvirus Agent Revenue by Type (2021-2032)
  3. 8.2.1 North America Anti-herpesvirus Agent Revenue by Type (2021-2026)
  4. 8.2.2 North America Anti-herpesvirus Agent Revenue by Type (2027-2032)
  5. 8.3 North America Anti-herpesvirus Agent Revenue Share by Type (2021-2032)
  6. 8.4 North America Anti-herpesvirus Agent Revenue by Application (2021-2032)
  7. 8.4.1 North America Anti-herpesvirus Agent Revenue by Application (2021-2026)
  8. 8.4.2 North America Anti-herpesvirus Agent Revenue by Application (2027-2032)
  9. 8.5 North America Anti-herpesvirus Agent Revenue Share by Application (2021-2032)
  10. 8.6 North America Anti-herpesvirus Agent Revenue by Country
  11. 8.6.1 North America Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Anti-herpesvirus Agent Revenue by Country (2021-2026)
  13. 8.6.3 North America Anti-herpesvirus Agent Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Anti-herpesvirus Agent Revenue (2021-2032)
  2. 9.2 Europe Anti-herpesvirus Agent Revenue by Type (2021-2032)
  3. 9.2.1 Europe Anti-herpesvirus Agent Revenue by Type (2021-2026)
  4. 9.2.2 Europe Anti-herpesvirus Agent Revenue by Type (2027-2032)
  5. 9.3 Europe Anti-herpesvirus Agent Revenue Share by Type (2021-2032)
  6. 9.4 Europe Anti-herpesvirus Agent Revenue by Application (2021-2032)
  7. 9.4.1 Europe Anti-herpesvirus Agent Revenue by Application (2021-2026)
  8. 9.4.2 Europe Anti-herpesvirus Agent Revenue by Application (2027-2032)
  9. 9.5 Europe Anti-herpesvirus Agent Revenue Share by Application (2021-2032)
  10. 9.6 Europe Anti-herpesvirus Agent Revenue by Country
  11. 9.6.1 Europe Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Anti-herpesvirus Agent Revenue by Country (2021-2026)
  13. 9.6.3 Europe Anti-herpesvirus Agent Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Anti-herpesvirus Agent Revenue (2021-2032)
  2. 10.2 China Anti-herpesvirus Agent Revenue by Type (2021-2032)
  3. 10.2.1 China Anti-herpesvirus Agent Revenue by Type (2021-2026)
  4. 10.2.2 China Anti-herpesvirus Agent Revenue by Type (2027-2032)
  5. 10.3 China Anti-herpesvirus Agent Revenue Share by Type (2021-2032)
  6. 10.4 China Anti-herpesvirus Agent Revenue by Application (2021-2032)
  7. 10.4.1 China Anti-herpesvirus Agent Revenue by Application (2021-2026)
  8. 10.4.2 China Anti-herpesvirus Agent Revenue by Application (2027-2032)
  9. 10.5 China Anti-herpesvirus Agent Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-herpesvirus Agent Revenue (2021-2032)
  2. 11.2 Asia Anti-herpesvirus Agent Revenue by Type (2021-2032)
  3. 11.2.1 Asia Anti-herpesvirus Agent Revenue by Type (2021-2026)
  4. 11.2.2 Asia Anti-herpesvirus Agent Revenue by Type (2027-2032)
  5. 11.3 Asia Anti-herpesvirus Agent Revenue Share by Type (2021-2032)
  6. 11.4 Asia Anti-herpesvirus Agent Revenue by Application (2021-2032)
  7. 11.4.1 Asia Anti-herpesvirus Agent Revenue by Application (2021-2026)
  8. 11.4.2 Asia Anti-herpesvirus Agent Revenue by Application (2027-2032)
  9. 11.5 Asia Anti-herpesvirus Agent Revenue Share by Application (2021-2032)
  10. 11.6 Asia Anti-herpesvirus Agent Revenue by Country
  11. 11.6.1 Asia Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Anti-herpesvirus Agent Revenue by Country (2021-2026)
  13. 11.6.3 Asia Anti-herpesvirus Agent Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-herpesvirus Agent Revenue (2021-2032)
  2. 12.2 SAMEA Anti-herpesvirus Agent Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Anti-herpesvirus Agent Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Anti-herpesvirus Agent Revenue by Type (2027-2032)
  5. 12.3 SAMEA Anti-herpesvirus Agent Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Anti-herpesvirus Agent Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Anti-herpesvirus Agent Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Anti-herpesvirus Agent Revenue by Application (2027-2032)
  9. 12.5 SAMEA Anti-herpesvirus Agent Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Anti-herpesvirus Agent Revenue by Country
  11. 12.6.1 SAMEA Anti-herpesvirus Agent Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Anti-herpesvirus Agent Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Anti-herpesvirus Agent Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst